Jubilant Life Sciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesPursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company is participating in the 10th Goldman Sachs India Pharma and Healthcare Tour on March 9, 2018 in the National Capital Region, India. We enclose details of investor/analyst meetings scheduled for the same.The schedule may undergo change due to exigencies on the part of Investors/Analysts/ Company.